Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Exogenous glutamine--compensating a shortage?

Inga Tjader1, Agneta Berg, Jan Wernerman

  • 1Department of Anesthesiology and Intensive Care Medicine, Karolinska University Hospital Huddinge, Stockholm, Sweden.

Critical Care Medicine
|September 22, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Net albumin leakage in patients in the ICU with suspected sepsis. A prospective analysis using mass balance calculations.

Critical care (London, England)·2025
Same author

Albumin and fibrinogen synthesis rates in advanced chronic liver disease.

American journal of physiology. Gastrointestinal and liver physiology·2023
Same author

Fibrinogen and albumin synthesis rates in major upper abdominal surgery.

PloS one·2022
Same author

Variability in Skeletal Muscle Protein Synthesis Rates in Critically Ill Patients.

Nutrients·2022
Same author

Medical nutrition therapy and clinical outcomes in critically ill adults: a European multinational, prospective observational cohort study (EuroPN).

Critical care (London, England)·2022
Same author

A guide to enteral nutrition in intensive care units: 10 expert tips for the daily practice.

Critical care (London, England)·2021
Same journal

The authors reply.

Critical care medicine·2026
Same journal

Attracting Emergency Medicine Graduates to Surgical Critical Care Training Programs.

Critical care medicine·2026
Same journal

The authors reply.

Critical care medicine·2026
Same journal

Beyond a Snapshot: Tracking Family Prognostic Expectations in the ICU.

Critical care medicine·2026
Same journal

The authors reply.

Critical care medicine·2026
Same journal

Plasma Levels of Soluble ST2 Reflect Extrapulmonary Organ Dysfunction and Predict Outcomes in Acute Respiratory Failure: Beware of Potential Confounders.

Critical care medicine·2026
See all related articles

Glutamine shortage impacts patient outcomes, especially during metabolic stress. Supplementing glutamine in critically ill patients improves survival and reduces complications, highlighting its physiological role.

Area of Science:

  • Biochemistry
  • Physiology
  • Critical Care Medicine

Background:

  • In vivo glutamine metabolism and homeostasis regulation remain poorly understood, particularly under metabolic stress.
  • Glutamine deficiency is linked to adverse outcomes, while adequate levels are crucial for cellular defense.
  • In intensive care units (ICUs), septic patients benefit from increased glutamine availability, reducing mortality and morbidity.

Purpose of the Study:

  • To investigate the role of glutamine metabolism and homeostasis during metabolic stress.
  • To evaluate the impact of plasma glutamine depletion and supplementation on critically ill patients.
  • To determine if exogenous glutamine supply constitutes pharmacologic treatment or physiological compensation.

Main Methods:

  • Review of existing literature on in vivo glutamine metabolism.

Related Experiment Videos

  • Analysis of clinical outcomes in critically ill patients with varying glutamine levels.
  • Assessment of cellular defense mechanisms' dependence on glutamine availability.
  • Main Results:

    • Plasma glutamine depletion is associated with poor outcomes in critically ill patients.
    • Supplementation of glutamine in clinical practice improves outcomes for the critically ill.
    • Increased metabolic demand necessitates increased glutamine consumption, which ordinary food cannot meet for patients with multiple organ failure.

    Conclusions:

    • Adequate glutamine availability is essential for cellular defense and optimal patient outcomes.
    • Exogenous glutamine supply in stressed states may represent physiological compensation rather than pharmacologic treatment.
    • Treating plasma glutamine depletion is clinically beneficial for the critically ill, suggesting a physiological requirement.